Zheng R, Chen J, Wang Q, Lyu J, et al. Fedratinib in chronic kidney disease: antifibrotic potential and renal safety signals from integrated network toxicology and pharmacovigilance. Ren Fail 2025;47:2590326.
PMID: 41414679